GL1X · GenesisL1 explorer

UniProt Q9NYY3

Serine/threonine-protein kinase PLK2 (Q9NYY3)

Serine/threonine-protein kinase PLK2 (UniProt Q9NYY3), EC 2.7.11.21: 14 experimental structures and 1 predicted model on GenesisL1, 7 ligands bound, 42 pockets. Binding sites, druggability and experiment against prediction…

UniProt
Q9NYY3
Protein
Serine/threonine-protein kinase PLK2
EC
2.7.11.21
Experimental structures
14
Predicted models
1
Ligands
7
Pockets
42 · 15 records with a druggable one

Structures

15 records of Q9NYY3 in the MolNFT archive: 14 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4I5MSelective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein…x-ray diffractionAR781 (best 0.66)
4I5MSelective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein…x-ray diffractionAR781 (best 0.66)
4I5PSelective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein…x-ray diffractionA1D11 (best 0.65)
4I5PSelective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein…x-ray diffractionA1D11 (best 0.65)
4I6BSelective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein…x-ray diffractionA11G1 (best 0.64)
4I6BSelective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein…x-ray diffractionA11G1 (best 0.64)
4I6FSelective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein…x-ray diffractionA1C72 (best 0.64)
4I6FSelective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein…x-ray diffractionA1C72 (best 0.64)
4I6HSelective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce alpha-Synuclein…x-ray diffractionA1C81 (best 0.66)
4I6HSelective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce alpha-synuclein…x-ray diffractionA1C81 (best 0.66)
4RS6Crystal structure of the C domain of Polo like Kinase II in Homo Sapiensx-ray diffractionA, B—5 (best 0.65)
4RS6Crystal structure of the C domain of polo like kinase II in homo sapiensx-ray diffractionA, B—5 (best 0.65)
4XB0Structure of the Plk2 polo-box domainx-ray diffractionA, BPO4, CL6 (best 0.65)
4XB0Structure of the PLK2 polo-box domainx-ray diffractionA, BPO4, CL6 (best 0.65)
Q9NYY3AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase PLK2 (Q9NYY3)predictedA—8 (best 0.69)

Ligands

  • 11G · (7R)-8-cyclopentyl-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one · in 2 records
  • 1C7 · (7R)-8-cyclopentyl-7-ethyl-5-methyl-2-(2-phenyl-1H-imidazol-1-yl)-7,8-dihydropteridin-6(5H)-one · in 2 records
  • 1C8 · (7R)-8-cyclopentyl-7-ethyl-5-methyl-2-[2-(1,3-thiazol-4-yl)-1H-imidazol-1-yl]-7,8-dihydropteridin-6(5H)-one · in 2 records
  • 1D1 · (7R)-8-cyclopentyl-7-ethyl-5-methyl-2-(1H-pyrrol-2-yl)-7,8-dihydropteridin-6(5H)-one · in 2 records
  • CL · Chloride ion · in 2 records
  • PO4 · Phosphate ion · in 2 records
  • R78 · 4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.